KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.25, sa.3, ss.272-279, 2015 (SCI-Expanded)
Objective: In this study, we aimed to investigate the effects of escitalopram, an antidepressant drug of the selective serotonin reuptake inhibitor group, on lipid peroxidation, nitric oxide (NO) level and superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in patients with major depressive disorder.